A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2825-2832

  Akamatsu, Y ^a   Murphy, J C ^a   Nolan, K F ^a   Thomas, P ^a   Kreitman, R J ^b   Leung, S O ^c   Junghans, R P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c IMMUNOMEDICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOTOXIN; IODINE 125;

ARTICLE; BIOASSAY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THERMOSTABILITY;

ADP RIBOSE TRANSFERASES; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTINEOPLASTIC AGENTS; BACTERIAL TOXINS; CARCINOEMBRYONIC ANTIGEN; CELL COUNT; COLORECTAL NEOPLASMS; EXOTOXINS; HUMANS; IMMUNOTOXINS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0031782883     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Schwartz, M. K. Cancer markers. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 531-542. Philadelphia: Lippincott, 1993.
2. Nap, M., Hammarstrom, M. L., Bormer, O., Hammarstrom, S., Wagener, C., Handt, S., Schreyer, M., Mach, J-P., Buchegger, F., von Kleist, S., Grunert, F., Seguin, P., Fuks, A., Holm, R., and Lamerz, R. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res., 52: 2329-2339, 1992.
3. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
4. Watanabe, Y., Miyazaki, H., and Osawa, T. Effect of a monoclonal anti-carcinoembryonic antigen antibody-ricin A-chain conjugate on human carcinoembryonic antigen producing tumor cells. J. Pharmacobiodyn., 7: 593-603, 1984.
5. Avila, A. D., Mateo de Acosta, C., and Lage, A. A carcinoembryonic antigen-directed immunotoxin built by linking a monoclonal antibody to a hemolytic toxin. Int. J. Cancer, 43: 926-929, 1989.
6. Richardson, V. J., Ford, C. H., Tsaltas, G., and Gallent, M. E. Doxorubicin anti-carcinoembryonic antigen immunoconjugate activity in vitro. Eur. J. Cancer Clin. Oncol., 25: 533-540, 1989.
7. Manosroi, J., von Kleist, S., Manosroi, A., and Grunert, F. Thermostability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin. J. Korean Med. Sci., 7: 128-135, 1992.
8. Tsai, L-C., Chen, Y-L., Lee, C., Chen, H-M., Chang, Z-N., Hung, M-W., Chao, P-L., and Lin, J-Y. Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate. Dis. Colon Rectum, 38: 1067-1074, 1995.
9. Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (Lond.), 339: 394-397, 1989.
10. Batra, J. K., Jinno, Y., Chaudhary, V. K., Kondo, T., Willingham, M. C., FitzGerald, D. J., and Pastan, I. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA, 86: 8545-8549, 1989.
11. Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M., and Pastan, I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA, 88: 8616-8620, 1991.
12. Pai, L. H., and Pastan, I. Immunotoxin therapy. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 3045-3057. Philadelphia: Lippincott-Raven, 1997.
13. Sharkey, R. M., Juweid, M., Shevitz, J., Behr, T., Dunn, R., Swayne, L. C., Wong, G. Y., Blumenthal, R. D., Griffiths, G. L., Siegel, J. A., Leung, S-O., Hansen, H. J., and Goldenberg, D. M. Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res., 55 (23 Suppl.): 5935-5945, 1995.
14. Niles, R. M., Wilhelm, S. A., Steele, G. D., Jr., Burke, B., Christensen, T., Dexter, D., O'Brien, M. J., Thomas, P., and Zamcheck, N. Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101). Cancer Invest., 5: 545-552, 1987.
15. Thomas, P., Gangopadhyay, A., Steele, G., Jr., Andrews, C., Nakazato, H., Oikawa, S., and Jessup, J. M. The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101. Cancer Lett., 92: 59-66, 1995.
16. Wu, X-C., Ng, S-C., Near, R. I., and Wong, S-L. Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system. Biotechnology, 11: 71-76, 1993.
17. Kreitman, R. J., Bailon, P., Chaudhary, V. K., FitzGerald, D. J. P., and Pastan, I. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood, 83: 426-434, 1994.
18. Buchner, J., Pastan, I., and Brinkmann, U. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem., 205: 263-270, 1992.
19. Junghans, R. P., Waldmann, T. A., Landolfi, N. F., Avdaloric, N. M., Schneider, W. P., and Queen, C. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res., 50: 1495-1502, 1990.
20. Junghans, R. P., Sgouros, G., and Scheinberg, D. B. Antibody-based immunotherapies for cancer. In: B. A. Chabner and D. L. Longo (eds.), Cancer Chemotherapy and Biotherapy: Principles and Practice, pp. 655-689. Lippincott: Philadelphia, 1996.
21. Brinkmann, U., Reiter, Y., Jung, S-H., Lee, B., and Pastan, I. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc. Natl. Acad. Sci. USA, 90: 7538-7542, 1993.
22. Junghans, R. P. Cruel antibody fictions! Cellular antigen enumeration by "saturation" binding, example CD3. Immunol. Today, in press, 1998.
23. Reiter, Y., Brinkmann, U., Webber, K. O., Jung, S-H., Lee, B., and Pastan, I. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv. Protein Eng., 7: 697-704, 1994.
24. Benhar, I., and Pastan, I. Characterisation of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice. Clin. Cancer Res., 1: 1023-1029, 1995.
25. Cournoyer, D., Beauchemin, N., Boucher, D., Benchmol, S., Fuks, A., and Stanners, C. Transcription of genes of the carcinoembryonic antigen family in malignant and nonmalignant human tissues. Cancer Res., 48: 3153-3157, 1988.
26. Boucher, D., Cournoyer, D., Stanners, C. P., and Fuks, A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res., 49: 847-852, 1989.
27. Ayala, M., Dueñas, M., Santos, A., Vázquez, J., Menéndez, A., Silva, A., and Gavilondo, J. V. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen. BioTechniques, 13: 790-799, 1992.
28. Abraham, R., Buxbaum, S., Link, J., Smith, R., Venti, C., and Darsley, M. Screening and kinetic analysis of recombinant anti-CEA antibody fragments. J. Immunol. Methods. 183: 119-125, 1995.
29. Verhaar, M. J., Chester, K. A., Keep, P. A., Robson, L., Pedley, R. B., Boden, J. A., Hawkins, R. E., and Begent, R. H. J. A single chain Fv derived from a filamentous phage library has distinct tumour targeting advantages over one derived from a hybridoma. Int. J. Cancer, 61: 497-501, 1995.
30. Toth, C. A., and Thomas, P. The effect of interteron treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro. J. Interferon Res., 10: 579-588, 1990.
31. Guadagni, F., Witt, P. L., Robbins, P. F., Schlom, J., and Greiner, J. W. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-γ. Cancer Res., 50: 6248-6255, 1990.
32. Junghans, R. P., and Waldmann, T. A. Metabolism of Tac (IL2Rα): physiology of cell surface shedding and renal elimination, and suppression of catabolism by antibody binding. J. Exp. Med., 183: 1587-1602, 1996.
33. Junghans, R. P., Carrisquillo, J. A., Waldmann, T. A. Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implication for dose selection in antibody immunotherapies. Proc. Natl. Acad. Sci. USA, 95: 1752-1757, 1998.
34. Kreitman, R. J., and Pastan, I. Targeting Pseudomonas exotoxin to hematologic malignancies. Semin. Cancer Biol., 6: 297-306, 1995.
35. Sharkey, R. M., Goldenberg, H., Lee, R. E., Ballance, C., Pawlyk, D., Varga, D., and Hansen, H. J. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res., 50: 2823-2831, 1990.
36. Mai, M., and Takahashi, Y. Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies: tumor marker doubling time and its half life period line. Hum. Cell, 6: 82-87, 1993.
37. Kreitman, R. J., Chaudhary, V. K., Waldmann, T. A., Hanchard, B., Cranston, B., FitzGerald, D. J., and Pastan, I. Cytotoxic activity of recombinant immunotoxins or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Leukemia (Baltimore), 7: 553-562, 1993.
38. Berson, S. A., and Yalow, R. S. Insulin in blood and insulin antibodies. Am. J. Med., 40: 676-690, 1966.
39. Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., and Maliszewski, C. R. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol., 151: 1235-1244, 1993.